3-cyclopropyl-4,5,6,7-tetrahydro-2H-indazole-5-carboxylic acid, 250mg

(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid, 98%, 100mg

(R)-2-((tert-Butoxycarbonyl)amino)-3,3-diphenylpropanoic acid, 95.0%, 5g

(S)-1-(4-Bromophenyl)-2,2-dimethylpropan-1-amine hydrochloride, 95%, 250mg

methyl 1-ethyl-4-nitro-1H-pyrazole-3-carboxylate, 1g

7H-PURINE-7-ACETAMIDE, 1,2,3,6-TETRAHYDRO-1,3-DIMETHYL-2,6-DIOXO-N-(6-PHENYL-3-PYRIDAZINYL)-, 98%, 10mg

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(methylamino)pyrrolidine-2-carboxylic acid, 98%, 1g

1-tert-Butyl 2-methyl 4-hydroxypiperidine-1,2-dicarboxylate, 95.0%, 250mg

(S)-N-((3-(3-Fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, 97%, 5g

Disodium oxalate, min. 99.5%, pa, ACS, 500 g, plastic packaging.

3-(3-Bromophenyl)pyridine, 95.0%, 1g

4-Bromo-1-ethyl-1H-pyrazole, 97.0%, 25g

2-Methyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propan-2-ol, 95.0%, 10g